noscript

News and Announcements

Oncosil Medical Group (ASX:OSL) Annual Update 2015; Shares Up Over 182%

  • Published January 05, 2016 2:42PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

2015 Highlights:

  • Share price up 182.35%
  • Completed the granted Fast Track review by the European regulator Conformité Européenne
  • International life sciences research group, Van Leeuwenhoeck Institute, initiated an analyst research coverage on the Company
  • Multiple new Board Appointments

ABOUT ONCOSIL MEDICAL GROUP:

OncoSil™ is a patent protected proprietary medical device (class III) that creates a localised stream of beta radiation. The product is created by melting up to 5% phosphorous in liquid silicon in a furnace which is then shattered into small particles using sterile water. The resulting radioactive phosphorous (P32) produces radioactive beta particles that can be emitted for up to three months.

Patients with unresectable pancreatic cancer have few treatment options. The current standard of care is to provide intravenous chemotherapy, and in some cases external beam radiation. The OncoSil™ is intended to complement existing standard of care chemotherapy.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now